Lineage Cell Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Lineage Cell Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$5.87M, a 16.8% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$25.6M, a 8.66% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$24.7M, a 9.83% decline from 2022.
  • Lineage Cell Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$22.5M, a 54.2% increase from 2021.
  • Lineage Cell Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$49.2M, a 86.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$24.7M -$2.21M -9.83% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$22.5M +$26.7M +54.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$49.2M -$22.8M -86.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$26.4M +$12.4M +32% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$38.9M +$2.92M +6.98% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$41.8M -$2.89M -7.44% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$38.9M +$20.1M +34% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 -$59M +$6.84M +10.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 -$65.8M -$15.1M -29.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$50.7M +$5.3M +9.47% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$56M -$31M -124% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 -$25M -$6.31M -33.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 -$18.7M -$8.83M -89.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 -$9.85M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.